Clinical Volume


With a very active heart and lung transplant program, as well as its regional leadership in advanced technology such as endovascular grafting, percutaneous valve implantation, and destination therapy circulatory support, Loyola performs cardiovascular and thoracic procedures far in excess of what can be staffed by our complement of categorical residents. This provides an environment where residents can involve themselves with those cases they believe will most benefit their education, while our surgical assistants cover the remainder.

Similarly, our dedicated Cardiovascular and Thoracic Intensive Care Unit is staffed by Anesthesia residents who carry out the majority of the 'front-line' care with the oversight of our trainees, so that our Thoracic residents are freed to pursue their technical development while building their clinical management skills. On the wards and in clinic, our team of Nurse Clinicians and Physician Assistants effectively manage inpatient and outpatient care with resident involvement as necessary.

Loyola Thoracic and Adult Cardiovascular Surgery

Thoracic and Cardiac FY 2018 chart

The figure above represents Cardiovascular Surgery volume for Fiscal Year 2018. 2018 shows growth across the board, with exceptional growth in such areas as our Bridge to Transplant/Destination Therapy VAD implantation and in Thoracoabdominal Aortic Surgery.

A substantial amount of our volume is valvular. Since the time of the early Heartport experience, Loyola has been a leader in minimally invasive valvular surgery, with particular preeminence in advanced mitral repair, and valve sparing aortic root procedures. The figure below highlights the stability of these volumes, and the extent to which they exceed resident coverage.

Cardiovascular Surgery Volume